SP221THE UTILITY OF KIDNEY INJURY BIOMARKERS COMBINED WITH CLINICAL COVARIATES FOR THE PREDICTION OF LONG-TERM ADVERSE OUTCOMES IN CRITICALLY ILL ADULTS. (13th June 2019)